Go Pro
LON:4BB

4basebio (4BB) Share Price, News & Analysis

4basebio logo
GBX 550 +30.25 (+5.82%)
As of 06:41 AM Eastern

About 4basebio Stock (LON:4BB)

Advanced

Key Stats

Today's Range
502.50
550
50-Day Range
450
550
52-Week Range
420
1,000
Volume
28 shs
Average Volume
1,397 shs
Market Capitalization
£85.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
GBX 1,400
Consensus Rating
Buy

Company Overview

4basebio is a specialist life sciences group focused on supplying therapeutic synthetic DNA for gene therapies and gene-based vaccines and providing solutions for effective and safe delivery of DNA/RNA based products to patients. Our focus is the development of high quality, GMP grade synthetic DNA as well as non-viral nanoparticles which can efficiently and safely deliver fully functional genes to patients. These products and technologies are also available for customers and partners with whom we endeavor to combine our capabilities and know-how to develop gene therapy solutions for clinical development and commercialisation.

Receive 4BB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for 4basebio and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

4BB Stock News Headlines

4basebio Plc - Grant of Options & Director/PDMR Dealing
Your book attached
Bill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.tc pixel
4basebio Plc - Director Appointment
4basebio Plc - Result of AGM & Issue of Options
See More Headlines

4BB Stock Analysis - Frequently Asked Questions

4basebio's stock was trading at GBX 600 on January 1st, 2026. Since then, 4BB stock has decreased by 13.4% and is now trading at GBX 519.75.

4basebio PLC (LON:4BB) announced its quarterly earnings results on Wednesday, May, 20th. The company reported ($1.09) earnings per share for the quarter. The business earned $1.69 million during the quarter.

Shares of 4BB stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that 4basebio investors own include B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), genedrive (GDR), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Company Calendar

Last Earnings
5/20/2026
Today
8/03/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
LON:4BB
CIK
N/A
Fax
N/A
Employees
101
Year Founded
N/A

Price Target and Rating

High Price Target
GBX 1,400
Low Price Target
GBX 1,400
Potential Upside/Downside
+154.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
GBX (109)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£9.84 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-231.29%
Return on Assets
-54.30%

Debt

Debt-to-Equity Ratio
201.47
Current Ratio
2.73
Quick Ratio
3.52

Sales & Book Value

Annual Sales
£1.69 million
Price / Sales
50.31
Cash Flow
GBX 34.21 per share
Price / Cash Flow
16.08
Book Value
GBX (41) per share
Price / Book
-13.41

Miscellaneous

Outstanding Shares
15,485,000
Free Float
N/A
Market Cap
£85.17 million
Optionable
Not Optionable
Beta
1.09
7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (LON:4BB) was last updated on 8/3/2026 by MarketBeat.com Staff.
From Our Partners